UBS AM
RGLS

UBS AM’s Regulus Therapeutics RGLS Stock Holding History

UBS AM’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,209
Closed -$479K – 2627
2016
Q3 		$479K Sell
1,209
-378
-24% -$155K ﹤0.01% 2004
2016
Q2 		$550K Sell
1,587
-20,797
-93% -$14.9M ﹤0.01% 1915
2016
Q1 		$18.6M Buy
22,384
+209
+0.9% +$166K 0.02% 688
2015
Q4 		$23.2M Buy
22,175
+3,733
+20% +$3.74M 0.03% 616
2015
Q3 		$14.5M Buy
18,442
+6,261
+51% +$6.43M 0.02% 771
2015
Q2 		$16M Buy
12,181
+3,036
+33% +$4.9M 0.02% 781
2015
Q1 		$18.6M Buy
9,145
+1,072
+13% +$2.33M 0.02% 732
2014
Q4 		$15.5M Buy
+8,073
New +$14.4M 0.01% 760

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return